Protein-based matrix interferences in ligand-binding assays

Area of Science:

• Biopharmaceutical Analysis
• Immunology
• Analytical Chemistry

Background:

• Biotherapeutic drug development necessitates robust bioanalytical methods.
• Ligand-binding assays are the primary platform for quantifying biotherapeutics and assessing immune responses.
• Biological matrices are complex and can interfere with assay accuracy.

Purpose of the Study:

• To review common matrix interferences in ligand-binding assays for biotherapeutics.
• To discuss the impact of various biological matrix components on assay results.
• To present practical strategies for mitigating matrix effects in bioanalysis.

Main Methods:

• Review of existing literature on bioanalytical methods for biotherapeutics.
• Analysis of common interfering factors in biological samples, such as rheumatoid factors and heterophilic antibodies.
• Discussion of techniques to minimize interference in ligand-binding assays.

Main Results:

• Matrix components like rheumatoid factors, heterophilic antibodies, and human anti-animal antibodies can cause significant interferences.
• These interferences can lead to inaccurate quantification of drug concentrations and immune responses.
• Various strategies exist to mitigate these interferences, improving assay reliability.

Conclusions:

• Understanding and addressing matrix interferences are critical for the successful bioanalysis of biotherapeutics.
• Effective mitigation strategies enhance the accuracy and reliability of ligand-binding assay results.
• This review provides valuable insights for optimizing bioanalytical support in biotherapeutic development.